Cargando…
Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study
BACKGROUND: Severe acute respiratory syndrome corona virus 2(SARS-CoV-2), the causative agent of corona virus disease-2019(COVID- 19) which has led to a global pandemic. The true extent of the burden of COVID-19 may be underestimated, and there is need to know the current prevalence of SARS-CoV-2 an...
Autores principales: | Jaiswal, Ram, Sharma, Shweta, Singla, Ashina, Devpura, Nimisha, Vohra, Rajat, Kakkar, Munish, Rijhwani, Puneet, Sureka, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645505/ https://www.ncbi.nlm.nih.gov/pubmed/34933819 http://dx.doi.org/10.1016/j.transci.2021.103338 |
Ejemplares similares
-
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
por: Uyoga, Sophie, et al.
Publicado: (2021) -
SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA
por: Johargy, Ayman K.
Publicado: (2009) -
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021) -
Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021) -
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
por: Mahallawi, Waleed H., et al.
Publicado: (2021)